Q3 2022 Clearside Biomedical Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Clearside Biomedical Inc third quarter 2022 Earnings Call. (Operator Instructions)
It is now my pleasure to turn the floor over to your host, Jenny Kobin, with Investor Relations. Ma'am, the floor is yours.
Good morning, and thank you for joining us on the call this morning. On today's call, we will have a brief discussion around Clearside's third quarter financials, followed by the results from the OASIS Phase I/IIa clinical trial. Before we begin, I would like to remind you that during today's call, we'll be making certain forward-looking statements. Various remarks that we may make during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.
Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |